Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2022-12-30 Regulatory Filings
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is titled 'Total Voting Rights' and explicitly states that it is conforming to 'DTR 5.6.1R' (Disclosure and Transparency Rules). It announces the total number of ordinary shares with voting rights (113,836,581) to be used as the denominator for shareholder notification calculations under the FCA's rules. This type of mandatory disclosure regarding the total share capital and voting rights is a standard regulatory announcement. Since it is a specific regulatory notification that doesn't fit the definitions for AGM-R, 10-K, ER, or DIV, the most appropriate classification is RNS (Regulatory Filings), which serves as the general category for such mandatory market disclosures not covered elsewhere. The document length is short (2627 chars), suggesting it is an announcement rather than a comprehensive report.
2022-12-30 English
Appointment of Geeta Gopalan as a NED
Board/Management Information Classification · 99% confidence The document is a formal announcement dated December 20, 2022, originating from Dechra Pharmaceuticals PLC, distributed via RNS (the news service of the London Stock Exchange). The core content announces the 'Appointment of Geeta Gopalan as Non-Executive Director' and details her committee memberships and retirement plans for another director. This directly relates to changes in the company's board of directors and senior management. This aligns perfectly with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter overrides the general 'Regulatory Filings' fallback.
2022-12-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as an 'RNS Number' filing from the London Stock Exchange's news service. The title section explicitly states 'TR-1: Standard form for notification of major holdings'. This form is used to report when an individual or entity's holding in a company's voting rights crosses a specific threshold. This type of filing directly corresponds to the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2022-12-15 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (2627 characters) and its primary purpose is to notify the market of the 'Total Voting Rights' as of a specific date (30 November 2022), citing DTR 5.6.1R. This notification establishes the denominator for shareholder interest calculations. While this relates to share capital, it is not a formal announcement of a share issue (SHA) or a transaction in own shares (POS). It is a mandatory regulatory disclosure concerning the total number of shares with voting rights. Since it is a specific regulatory notification that doesn't fit the other precise categories (like DIRS, DIV, or CAP), and it is issued via RNS, it falls best under the general 'Regulatory Filings' category (RNS) as a mandatory disclosure update, or potentially DVA if it were related to a vote result, but here it is purely a rights count. Given the context of mandatory disclosure via RNS, RNS is the most appropriate general classification.
2022-11-30 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (2625 characters) and is explicitly identified as an 'RNS Number' filing from the London Stock Exchange's news service. The content announces the 'Total Voting Rights' as of a specific date (October 31, 2022), stating the total number of shares with voting rights (113,824,672). This type of mandatory notification regarding the total share capital used as a denominator for disclosure rules (DTR 5.6.1R) is a standard regulatory announcement. While it relates to share capital, it is not a formal share issue (SHA) or a transaction in own shares (POS), but rather a periodic disclosure requirement. Given the source (RNS) and the nature of the announcement (a mandatory notification about voting rights denominator), the most appropriate classification is the general regulatory announcement category, RNS, as it is a standard, non-specific regulatory update provided via the RNS system.
2022-10-31 English
Group of companies' accounts made up to 2022-06-30
Regulatory Filings
2022-10-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.